ASPH - aspartate beta-hydroxylase Gene
Also Known as AAH; BAH; HAAH; JCTN; FDLAB; junctin; CASQ2BP1
Species: Homo sapiens
About ASPH
This gene has 30 transcripts (splice variants), 208 orthologues, 2 paralogues and is associated with 4 phenotypes. Broad expression in fat (RPKM 85.5), adrenal (RPKM 27.8) and 21 other tissues.
Summary
This gene is thought to play an important role in calcium homeostasis. The gene is expressed from two promoters and undergoes extensive alternative splicing. The encoded set of proteins share varying amounts of overlap near their N-termini but have substantial variations in their C-terminal domains resulting in distinct functional properties. The longest isoforms (a and f) include a C-terminal Aspartyl/Asparaginyl beta-hydroxylase domain that hydroxylates aspartic acid or asparagine residues in the epidermal growth factor (EGF)-like domains of some proteins, including protein C, coagulation factors VII, IX, and X, and the complement factors C1R and C1S. Other isoforms differ primarily in the C-terminal sequence and lack the hydroxylase domain, and some have been localized to the endoplasmic and sarcoplasmic reticulum. Some of these isoforms are found in complexes with calsequestrin, triadin, and the ryanodine receptor, and have been shown to regulate calcium release from the sarcoplasmic reticulum. Some isoforms have been implicated in metastasis. [provided by RefSeq, Sep 2009]
ASPH Products (77)
| mRNA | Protein | Name |
|---|---|---|
| NM_001164750.2 | NP_001158222.1 | aspartyl/asparaginyl beta-hydroxylase isoform 6 |
| NM_001164751.2 | NP_001158223.1 | aspartyl/asparaginyl beta-hydroxylase isoform 7 |
| NM_001164752.2 | NP_001158224.1 | aspartyl/asparaginyl beta-hydroxylase isoform 8 |
| NM_001164753.2 | NP_001158225.1 | aspartyl/asparaginyl beta-hydroxylase isoform 9 |
| NM_001164754.2 | NP_001158226.1 | aspartyl/asparaginyl beta-hydroxylase isoform 10 |
| NM_001164755.2 | NP_001158227.1 | aspartyl/asparaginyl beta-hydroxylase isoform 11 |
| NM_001164756.2 | NP_001158228.1 | aspartyl/asparaginyl beta-hydroxylase isoform 12 |
| NM_001413844.1 | NP_001400773.1 | aspartyl/asparaginyl beta-hydroxylase isoform 13 |
| NM_001413845.1 | NP_001400774.1 | aspartyl/asparaginyl beta-hydroxylase isoform 14 |
| NM_001413846.1 | NP_001400775.1 | aspartyl/asparaginyl beta-hydroxylase isoform 15 |
| NM_001413847.1 | NP_001400776.1 | aspartyl/asparaginyl beta-hydroxylase isoform 16 |
| NM_001413848.1 | NP_001400777.1 | aspartyl/asparaginyl beta-hydroxylase isoform 17 |
| NM_001413849.1 | NP_001400778.1 | aspartyl/asparaginyl beta-hydroxylase isoform 1 |
| NM_001413850.1 | NP_001400779.1 | aspartyl/asparaginyl beta-hydroxylase isoform 18 |
| NM_001413851.1 | NP_001400780.1 | aspartyl/asparaginyl beta-hydroxylase isoform 18 |
| NM_001413852.1 | NP_001400781.1 | aspartyl/asparaginyl beta-hydroxylase isoform 19 |
| NM_001413853.1 | NP_001400782.1 | aspartyl/asparaginyl beta-hydroxylase isoform 20 |
| NM_001413854.1 | NP_001400783.1 | aspartyl/asparaginyl beta-hydroxylase isoform 21 |
| NM_001413855.1 | NP_001400784.1 | aspartyl/asparaginyl beta-hydroxylase isoform 21 |
| NM_001413856.1 | NP_001400785.1 | aspartyl/asparaginyl beta-hydroxylase isoform 21 |
| NM_001413857.1 | NP_001400786.1 | aspartyl/asparaginyl beta-hydroxylase isoform 22 |
| NM_001413858.1 | NP_001400787.1 | aspartyl/asparaginyl beta-hydroxylase isoform 23 |
| NM_001413859.1 | NP_001400788.1 | aspartyl/asparaginyl beta-hydroxylase isoform 23 |
| NM_001413860.1 | NP_001400789.1 | aspartyl/asparaginyl beta-hydroxylase isoform 24 |
| NM_001413861.1 | NP_001400790.1 | aspartyl/asparaginyl beta-hydroxylase isoform 25 |
| NM_001413862.1 | NP_001400791.1 | aspartyl/asparaginyl beta-hydroxylase isoform 26 |
| NM_001413863.1 | NP_001400792.1 | aspartyl/asparaginyl beta-hydroxylase isoform 27 |
| NM_001413864.1 | NP_001400793.1 | aspartyl/asparaginyl beta-hydroxylase isoform 6 |
| NM_001413865.1 | NP_001400794.1 | aspartyl/asparaginyl beta-hydroxylase isoform 6 |
| NM_001413866.1 | NP_001400795.1 | aspartyl/asparaginyl beta-hydroxylase isoform 6 |
| NM_001413867.1 | NP_001400796.1 | aspartyl/asparaginyl beta-hydroxylase isoform 28 |
| NM_001413868.1 | NP_001400797.1 | aspartyl/asparaginyl beta-hydroxylase isoform 28 |
| NM_001413869.1 | NP_001400798.1 | aspartyl/asparaginyl beta-hydroxylase isoform 29 |
| NM_001413870.1 | NP_001400799.1 | aspartyl/asparaginyl beta-hydroxylase isoform 30 |
| NM_001413871.1 | NP_001400800.1 | aspartyl/asparaginyl beta-hydroxylase isoform 31 |
| NM_001413872.1 | NP_001400801.1 | aspartyl/asparaginyl beta-hydroxylase isoform 31 |
| NM_001413873.1 | NP_001400802.1 | aspartyl/asparaginyl beta-hydroxylase isoform 32 |
| NM_001413874.1 | NP_001400803.1 | aspartyl/asparaginyl beta-hydroxylase isoform 33 |
| NM_001413875.1 | NP_001400804.1 | aspartyl/asparaginyl beta-hydroxylase isoform 34 |
| NM_001413876.1 | NP_001400805.1 | aspartyl/asparaginyl beta-hydroxylase isoform 35 |
| NM_001413877.1 | NP_001400806.1 | aspartyl/asparaginyl beta-hydroxylase isoform 35 |
| NM_001413878.1 | NP_001400807.1 | aspartyl/asparaginyl beta-hydroxylase isoform 36 |
| NM_001413879.1 | NP_001400808.1 | aspartyl/asparaginyl beta-hydroxylase isoform 37 |
| NM_001413880.1 | NP_001400809.1 | aspartyl/asparaginyl beta-hydroxylase isoform 38 |
| NM_001413881.1 | NP_001400810.1 | aspartyl/asparaginyl beta-hydroxylase isoform 39 |
| NM_001413882.1 | NP_001400811.1 | aspartyl/asparaginyl beta-hydroxylase isoform 40 |
| NM_001413883.1 | NP_001400812.1 | aspartyl/asparaginyl beta-hydroxylase isoform 41 |
| NM_001413884.1 | NP_001400813.1 | aspartyl/asparaginyl beta-hydroxylase isoform 42 |
| NM_001413885.1 | NP_001400814.1 | aspartyl/asparaginyl beta-hydroxylase isoform 43 |
| NM_001413886.1 | NP_001400815.1 | aspartyl/asparaginyl beta-hydroxylase isoform 44 |
| NM_001413887.1 | NP_001400816.1 | aspartyl/asparaginyl beta-hydroxylase isoform 44 |
| NM_001413888.1 | NP_001400817.1 | aspartyl/asparaginyl beta-hydroxylase isoform 45 |
| NM_001413889.1 | NP_001400818.1 | aspartyl/asparaginyl beta-hydroxylase isoform 46 |
| NM_001413890.1 | NP_001400819.1 | aspartyl/asparaginyl beta-hydroxylase isoform 47 |
| NM_001413891.1 | NP_001400820.1 | aspartyl/asparaginyl beta-hydroxylase isoform 48 |
| NM_001413893.1 | NP_001400822.1 | aspartyl/asparaginyl beta-hydroxylase isoform 49 |
| NM_001413894.1 | NP_001400823.1 | aspartyl/asparaginyl beta-hydroxylase isoform 50 |
| NM_001413895.1 | NP_001400824.1 | aspartyl/asparaginyl beta-hydroxylase isoform 51 |
| NM_001413896.1 | NP_001400825.1 | aspartyl/asparaginyl beta-hydroxylase isoform 52 |
| NM_001413897.1 | NP_001400826.1 | aspartyl/asparaginyl beta-hydroxylase isoform 53 |
| NM_001413898.1 | NP_001400827.1 | aspartyl/asparaginyl beta-hydroxylase isoform 54 |
| NM_001413899.1 | NP_001400828.1 | aspartyl/asparaginyl beta-hydroxylase isoform 55 |
| NM_001413900.1 | NP_001400829.1 | aspartyl/asparaginyl beta-hydroxylase isoform 56 |
| NM_001413901.1 | NP_001400830.1 | aspartyl/asparaginyl beta-hydroxylase isoform 58 |
| NM_001413902.1 | NP_001400831.1 | aspartyl/asparaginyl beta-hydroxylase isoform 2 |
| NM_001413903.1 | NP_001400832.1 | aspartyl/asparaginyl beta-hydroxylase isoform 59 |
| NM_001413904.1 | NP_001400833.1 | aspartyl/asparaginyl beta-hydroxylase isoform 60 |
| NM_001413905.1 | NP_001400834.1 | aspartyl/asparaginyl beta-hydroxylase isoform 61 |
| NM_001413906.1 | NP_001400835.1 | aspartyl/asparaginyl beta-hydroxylase isoform 62 |
| NM_001413907.1 | NP_001400836.1 | aspartyl/asparaginyl beta-hydroxylase isoform 63 |
| NM_001413908.1 | NP_001400837.1 | aspartyl/asparaginyl beta-hydroxylase isoform 64 |
| NM_001413909.1 | NP_001400838.1 | aspartyl/asparaginyl beta-hydroxylase isoform 57 |
| NM_004318.4 | NP_004309.2 | aspartyl/asparaginyl beta-hydroxylase isoform 1 |
| NM_020164.5 | NP_064549.1 | aspartyl/asparaginyl beta-hydroxylase isoform 5 |
| NM_032466.4 | NP_115855.1 | aspartyl/asparaginyl beta-hydroxylase isoform 3 |
| NM_032467.4 | NP_115856.1 | aspartyl/asparaginyl beta-hydroxylase isoform 4 |
| NM_032468.5 | NP_115857.1 | aspartyl/asparaginyl beta-hydroxylase isoform 2 |
| Molecular Function GO Annotation | Evidence | Verweise | Source |
|---|---|---|---|
| enables calcium ion binding |
IDA
IDA: Inferred from direct assay
|
22586105 | GOA |
| enables protein binding |
IPI
IPI: Inferred from physical interaction
|
21062895 | GOA |
| Cellular Component GO Annotation | Evidence | Verweise | Source |
|---|---|---|---|
| located in cortical endoplasmic reticulum |
IDA
IDA: Inferred from direct assay
|
21062895 | GOA |
| located in endoplasmic reticulum membrane |
IDA
IDA: Inferred from direct assay
|
22586105 | GOA |
| located in plasma membrane |
IDA
IDA: Inferred from direct assay
|
21062895 | GOA |
ASPH Protein Structure
Asp-B-Hydro_N: Aspartyl beta-hydroxylase N-terminal region (43 - 310)
TPR_16: Tetratricopeptide repeat (345 - 402)
Asp_Arg_Hydrox: Aspartyl/Asparaginyl beta-hydroxylase (590 - 746)
- 0
- 200
- 400
- 600
- 758 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
aspartyl/asparaginyl beta-hydroxylase |
|
ASPH Protein-protein interaction Information
|
Type
|
Protein Name | Protein ID | Interactor | Interactor Species | Interactor ID | Detection Method | Verweise |
|---|---|---|---|---|---|---|---|
|
Intra
|
ASPH | Q12797 | GET3 | Homo sapiens | O43681 | 25416956 | |
|
Intra
|
ASPH | Q12797 | GET3 | Homo sapiens | O43681 | 25416956 |
Recombinant ASPH Proteins
| Art. -Nr. | Produktname | Accession | Reinheit |
|---|---|---|---|
| HY-P72092 | ASPH Protein, Human (His-SUMO) | Q12797-6 (F75-T270) | ≥ 90%, as determined by reducing SDS-PAGE. |
Related Diseases
| Diseases | Alias | |
|---|---|---|
| Facial Dysmorphism, Lens Dislocation, Anterior Segment Abnormalities, And Spontaneous Filtering Blebs |
|
|
| Exercise-Induced Malignant Hyperthermia |
|
|
| Malignant Hyperthermia |
|
|
| Malignant Hyperthermia Susceptibility |
|
|
| Malignant Hyperthermia Of Anesthesia |
|
|
| Malignant Hyperthermia 1 |
|
|
| Catecholaminergic Polymorphic Ventricular Tachycardia |
|
|
| Regular Astigmatism |
|
|
| Cholangiocarcinoma |
|
|
| Central Core Disease Of Muscle |
|
|
| Microcephaly 1, Primary, Autosomal Recessive |
|
|
| Seckel Syndrome 5 |
|
|
| Malignant Secondary Hypertension |
|
|
| Ventricular Tachycardia, Catecholaminergic Polymorphic, 2 |
|
|
| Multiminicore Disease |
|
|
| Marfan Syndrome |
|
|
| Cartilage-Hair Hypoplasia |
|
|
| Meier-Gorlin Syndrome 1 |
|
|
| Heart Disease |
|
|
| Myopathy |
|
Orthologs Information
| Species | Symbol | Source | ID |
|---|---|---|---|
| Bos taurus | ASPH | VGNC | VGNC:26219 |
| Macaca mulatta | ASPH | VGNC | VGNC:70166 |
| Rattus norvegicus | ASPH | RGD | RGD:1312000 |
| Felis catus | ASPH | VGNC | VGNC:81667 |
| Mus musculus | ASPH | MGD | MGI:1914186 |
| Canis familiaris | ASPH | VGNC | VGNC:38186 |
| Others | ASPH | NCBI |